Minor
Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Xianglin YuanPhase 1/2 NCT06592287 Registry history of NCT06592287 on ClinicalTrials.gov (opens the registry)
Changed